sum m ary m arch 2021 anti foxp3 pe cy7 3g3 tonbo anti foxp3 percp cy5 5 (Cytek Biosciences)
Cytek Biosciences is a verified supplier 
Cytek Biosciences manufactures this product 
93
Structured Review
Cytek Biosciences
sum m ary m arch 2021 anti foxp3 pe cy7 3g3 tonbo anti foxp3 percp cy5 5
Sum M Ary M Arch 2021 Anti Foxp3 Pe Cy7 3g3 Tonbo Anti Foxp3 Percp Cy5 5, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sum+m+ary+m+arch+2021+anti+foxp3+pe+cy7+3g3+tonbo+anti+foxp3+percp+cy5+5/PE-Cyanine5+Anti-Mouse+Foxp3/pm35794484-509-143-152
Average 93 stars, based on 4 article reviews
Sum M Ary M Arch 2021 Anti Foxp3 Pe Cy7 3g3 Tonbo Anti Foxp3 Percp Cy5 5, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sum+m+ary+m+arch+2021+anti+foxp3+pe+cy7+3g3+tonbo+anti+foxp3+percp+cy5+5/PE-Cyanine5+Anti-Mouse+Foxp3/pm35794484-509-143-152
Average 93 stars, based on 4 article reviews
sum m ary m arch 2021 anti foxp3 pe cy7 3g3 tonbo anti foxp3 percp cy5 5 - by Bioz Stars,
2026-11
93/100 stars
Images
Related Articles
Chromatin Immunoprecipitation:Article Title: Immune tolerance of food is mediated by layers of CD4 + T cell dysfunction. Article Snippet: .. Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology and archaeology Animals and other organisms Human research participants Clinical data Dual use research of concern Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used Antibodies Source anti-CD4 APC-ef780 (RM4-5) Invitrogen anti-CD44 BUV395 (IM7) BD anti-CD44 PB (IM7) BD anti-CD11c BV510 (N418) Biolegend anti-CD8a BV510 (54-6.7) Biolegend anti-CD11b BV510 (M1/70) Biolegend anti-B220 BV510 (RA3-6B2) Biolegend anti-CXCR5 BV650 (L138D7) Biolegend anti-FR4 FITC (12A5) Biolegend anti-CD73 BV605 (TY/11.8) Biolegend anti-CD200 APC-R700 (OX90) BD anti-CTLA4 PerCPCy5.5 (UC10-4B9) Biolegend anti-CD25 BV421 (PC61) BD anti-PD1 BV786 (29F.1A12) Biolegend anti-CCR7 PerCPCy5.5 (4B12) Invitrogen anti-ICOS BV605 (C398.4A) Biolegend anti-CD62L BV711 (MEL14) Biolegend anti-T-bet PE (ebio4B10) Invitrogen anti-T-bet PE-Cy7 (ebio4B10) Invitrogen anti-T-bet BV421 (4B10) Biolegend anti-GATA3 PE (L50-823) BD anti-RORgt PerCP-Cy5.5 (q31-376) BD anti-Bcl6 BV421 (K112-91) BD 3 nature portfolio | reporting Flow Cytometry:Article Title: Immune tolerance of food is mediated by layers of CD4 + T cell dysfunction. Article Snippet: .. Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology and archaeology Animals and other organisms Human research participants Clinical data Dual use research of concern Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used Antibodies Source anti-CD4 APC-ef780 (RM4-5) Invitrogen anti-CD44 BUV395 (IM7) BD anti-CD44 PB (IM7) BD anti-CD11c BV510 (N418) Biolegend anti-CD8a BV510 (54-6.7) Biolegend anti-CD11b BV510 (M1/70) Biolegend anti-B220 BV510 (RA3-6B2) Biolegend anti-CXCR5 BV650 (L138D7) Biolegend anti-FR4 FITC (12A5) Biolegend anti-CD73 BV605 (TY/11.8) Biolegend anti-CD200 APC-R700 (OX90) BD anti-CTLA4 PerCPCy5.5 (UC10-4B9) Biolegend anti-CD25 BV421 (PC61) BD anti-PD1 BV786 (29F.1A12) Biolegend anti-CCR7 PerCPCy5.5 (4B12) Invitrogen anti-ICOS BV605 (C398.4A) Biolegend anti-CD62L BV711 (MEL14) Biolegend anti-T-bet PE (ebio4B10) Invitrogen anti-T-bet PE-Cy7 (ebio4B10) Invitrogen anti-T-bet BV421 (4B10) Biolegend anti-GATA3 PE (L50-823) BD anti-RORgt PerCP-Cy5.5 (q31-376) BD anti-Bcl6 BV421 (K112-91) BD 3 nature portfolio | reporting Magnetic Resonance Imaging:Article Title: Immune tolerance of food is mediated by layers of CD4 + T cell dysfunction. Article Snippet: .. Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology and archaeology Animals and other organisms Human research participants Clinical data Dual use research of concern Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used Antibodies Source anti-CD4 APC-ef780 (RM4-5) Invitrogen anti-CD44 BUV395 (IM7) BD anti-CD44 PB (IM7) BD anti-CD11c BV510 (N418) Biolegend anti-CD8a BV510 (54-6.7) Biolegend anti-CD11b BV510 (M1/70) Biolegend anti-B220 BV510 (RA3-6B2) Biolegend anti-CXCR5 BV650 (L138D7) Biolegend anti-FR4 FITC (12A5) Biolegend anti-CD73 BV605 (TY/11.8) Biolegend anti-CD200 APC-R700 (OX90) BD anti-CTLA4 PerCPCy5.5 (UC10-4B9) Biolegend anti-CD25 BV421 (PC61) BD anti-PD1 BV786 (29F.1A12) Biolegend anti-CCR7 PerCPCy5.5 (4B12) Invitrogen anti-ICOS BV605 (C398.4A) Biolegend anti-CD62L BV711 (MEL14) Biolegend anti-T-bet PE (ebio4B10) Invitrogen anti-T-bet PE-Cy7 (ebio4B10) Invitrogen anti-T-bet BV421 (4B10) Biolegend anti-GATA3 PE (L50-823) BD anti-RORgt PerCP-Cy5.5 (q31-376) BD anti-Bcl6 BV421 (K112-91) BD 3 nature portfolio | reporting Biomarker Discovery:Article Title: Immune tolerance of food is mediated by layers of CD4 + T cell dysfunction. Article Snippet: .. Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology and archaeology Animals and other organisms Human research participants Clinical data Dual use research of concern Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used Antibodies Source anti-CD4 APC-ef780 (RM4-5) Invitrogen anti-CD44 BUV395 (IM7) BD anti-CD44 PB (IM7) BD anti-CD11c BV510 (N418) Biolegend anti-CD8a BV510 (54-6.7) Biolegend anti-CD11b BV510 (M1/70) Biolegend anti-B220 BV510 (RA3-6B2) Biolegend anti-CXCR5 BV650 (L138D7) Biolegend anti-FR4 FITC (12A5) Biolegend anti-CD73 BV605 (TY/11.8) Biolegend anti-CD200 APC-R700 (OX90) BD anti-CTLA4 PerCPCy5.5 (UC10-4B9) Biolegend anti-CD25 BV421 (PC61) BD anti-PD1 BV786 (29F.1A12) Biolegend anti-CCR7 PerCPCy5.5 (4B12) Invitrogen anti-ICOS BV605 (C398.4A) Biolegend anti-CD62L BV711 (MEL14) Biolegend anti-T-bet PE (ebio4B10) Invitrogen anti-T-bet PE-Cy7 (ebio4B10) Invitrogen anti-T-bet BV421 (4B10) Biolegend anti-GATA3 PE (L50-823) BD anti-RORgt PerCP-Cy5.5 (q31-376) BD anti-Bcl6 BV421 (K112-91) BD 3 nature portfolio | reporting |